相似文献
1
Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation.
Front Oncol. 2023 Dec 19;13:1321334. doi: 10.3389/fonc.2023.1321334. eCollection 2023.
2
Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation.
Front Oncol. 2023 Aug 28;13:1196564. doi: 10.3389/fonc.2023.1196564. eCollection 2023.
3
Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Klin Padiatr. 2004 Nov-Dec;216(6):356-63. doi: 10.1055/s-2004-832357.
4
Caspase inhibitor ZVAD-fmk facilitates engraftment of donor hematopoietic stem cells in intra-bone marrow-bone marrow transplantation.
Stem Cells Dev. 2010 Apr;19(4):461-8. doi: 10.1089/scd.2009.0251.
5
The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
Biol Blood Marrow Transplant. 2002;8(11):588-96. doi: 10.1053/bbmt.2002.v8.abbmt080588.
6
Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
Transplant Cell Ther. 2023 Apr;29(4):273.e1-273.e9. doi: 10.1016/j.jtct.2023.01.005. Epub 2023 Jan 12.
7
Bone marrow transplantation for autoimmune diseases.
Acta Haematol. 1998;99(3):116-32. doi: 10.1159/000040826.
8
[Maintenance therapy following CD19 CAR-T treatment for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Zhonghua Xue Ye Xue Za Zhi. 2020 Jun 14;41(6):495-501. doi: 10.3760/cma.j.issn.0253-2727.2020.06.011.
9
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report.
Biomark Res. 2020 Aug 31;8:36. doi: 10.1186/s40364-020-00216-1. eCollection 2020.
10
Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.
Blood. 2003 Jan 15;101(2):446-53. doi: 10.1182/blood-2002-05-1615. Epub 2002 Sep 12.
引用本文的文献
1
(Donor) age is more than just a number….
Bone Marrow Transplant. 2025 Jan;60(1):1-2. doi: 10.1038/s41409-024-02420-1. Epub 2024 Oct 4.
本文引用的文献
1
Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials.
Front Immunol. 2023 Jun 20;14:1211171. doi: 10.3389/fimmu.2023.1211171. eCollection 2023.
2
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Haematologica. 2023 Dec 1;108(12):3321-3332. doi: 10.3324/haematol.2023.283426.
3
Donor Age Influences Graft-Versus-Host Disease Relapse-Free Survival after Allogeneic Stem Cell Transplant in Elderly Patients in Two Countries from Latin America.
Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):330-336. doi: 10.56875/2589-0646.1042.
4
Posttransplant cyclophosphamide beyond haploidentical transplantation.
Ann Hematol. 2024 May;103(5):1483-1491. doi: 10.1007/s00277-023-05300-8. Epub 2023 Jun 1.
5
Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease.
Pharmaceuticals (Basel). 2023 Mar 30;16(4):512. doi: 10.3390/ph16040512.
6
Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review.
Front Med (Lausanne). 2023 Feb 23;10:1036939. doi: 10.3389/fmed.2023.1036939. eCollection 2023.
7
Hematopoietic Stem Cell Transplantation in Thalassemia.
Hematol Oncol Clin North Am. 2023 Apr;37(2):413-432. doi: 10.1016/j.hoc.2022.12.009.
8
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.
Transplant Cell Ther. 2023 May;29(5):338.e1-338.e6. doi: 10.1016/j.jtct.2023.01.031. Epub 2023 Feb 10.
9
Interprofessional Team-based Care of the Hematopoietic Cell Transplantation Patient With Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome.
J Pediatr Hematol Oncol. 2023 Jan 1;45(1):12-17. doi: 10.1097/MPH.0000000000002594. Epub 2022 Nov 21.
10
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues.
Lancet Haematol. 2022 Aug;9(8):e605-e614. doi: 10.1016/S2352-3026(22)00184-3.
Zotero 插件